| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Assessing Competing Risks for Death Following Liver Transplantation for Hepatocellular Carcinoma
|
Sposito, Carlo
|
|
2019
|
64 |
4 |
p. 1001-1007
|
artikel
|
| 2 |
Biomarkers: What Role Do They Play (If Any) for Diagnosis, Prognosis and Tumor Response Prediction for Hepatocellular Carcinoma?
|
Harding, James J.
|
|
2019
|
64 |
4 |
p. 918-927
|
artikel
|
| 3 |
Changing Epidemiology of HCC: How to Screen and Identify Patients at Risk?
|
Lange, Naomi
|
|
2019
|
64 |
4 |
p. 903-909
|
artikel
|
| 4 |
Current State of Tumor Ablation Therapies
|
Bailey, Christopher W.
|
|
2019
|
64 |
4 |
p. 951-958
|
artikel
|
| 5 |
Design and Endpoints of Clinical Trials, Current and Future
|
Sherman, Morris
|
|
2019
|
64 |
4 |
p. 1050-1057
|
artikel
|
| 6 |
Disease Burden of Hepatocellular Carcinoma: A Global Perspective
|
Sayiner, Mehmet
|
|
2019
|
64 |
4 |
p. 910-917
|
artikel
|
| 7 |
Emerging Role of the Pathologist in Precision Medicine for HCC
|
Longerich, Thomas
|
|
2019
|
64 |
4 |
p. 928-933
|
artikel
|
| 8 |
HCC: Transarterial Therapies—What the Interventional Radiologist Can Offer
|
Vogl, Thomas J.
|
|
2019
|
64 |
4 |
p. 959-967
|
artikel
|
| 9 |
Hepatocellular Carcinoma: Current Imaging Modalities for Diagnosis and Prognosis
|
Ronot, Maxime
|
|
2019
|
64 |
4 |
p. 934-950
|
artikel
|
| 10 |
Immunotherapy: Current Status and Future Perspectives
|
Floudas, Charalampos S.
|
|
2019
|
64 |
4 |
p. 1030-1040
|
artikel
|
| 11 |
Immunotherapy: Current Status and Future Perspectives
|
Floudas, Charalampos S.
|
|
|
64 |
4 |
p. 1030-1040
|
artikel
|
| 12 |
Introduction to the Emmet B. Keeffe, MD, Commemorative Special Issue on Hepatocellular Carcinoma
|
Fuchs, Michael
|
|
2019
|
64 |
4 |
p. 901-902
|
artikel
|
| 13 |
Liver Allocation Policies in the USA: Past, Present, and the Future
|
Pillai, Anjana
|
|
2019
|
64 |
4 |
p. 985-992
|
artikel
|
| 14 |
Living Donor Liver Transplantation for Hepatocellular Carcinoma: An Asian Perspective
|
Yoon, Young-In
|
|
2019
|
64 |
4 |
p. 993-1000
|
artikel
|
| 15 |
Multidisciplinary Approach to HCC Management: How Can This Be Done?
|
Gadsden, Melissa M.
|
|
2019
|
64 |
4 |
p. 968-975
|
artikel
|
| 16 |
Obtaining Optimal Long-Term Outcomes from Liver Transplantation for Hepatocellular Cancer
|
Reichman, Trevor W.
|
|
2019
|
64 |
4 |
p. 976-984
|
artikel
|
| 17 |
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current State and Future Opportunities
|
Soni, Payal D.
|
|
2019
|
64 |
4 |
p. 1008-1015
|
artikel
|
| 18 |
Systemic Management for Advanced Hepatocellular Carcinoma: A Review of the Molecular Pathways of Carcinogenesis, Current and Emerging Therapies, and Novel Treatment Strategies
|
Saffo, Saad
|
|
2019
|
64 |
4 |
p. 1016-1029
|
artikel
|
| 19 |
What Comes First: Treatment of Viral Hepatitis or Liver Cancer?
|
Feld, Jordan J.
|
|
2019
|
64 |
4 |
p. 1041-1049
|
artikel
|
Tijdschrift beschrijving